Cargando...
Fibroblast growth factor 21 mediates glycemic regulation by hepatic JNK
The cJun NH(2)-terminal kinase (JNK) signaling pathway is implicated in metabolic syndrome, including dysregulated blood glucose concentration and insulin resistance. Fibroblast growth factor 21 (FGF21) is a target of the hepatic JNK signaling pathway and may contribute to the regulation of glycemia...
Gardado en:
| Publicado en: | Cell Rep |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4794343/ https://ncbi.nlm.nih.gov/pubmed/26947074 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.celrep.2016.02.026 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|